MedTrace Logo

A Study of ART105 in Healthy Adult Participants

NCT07748026 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-08-05

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if ART105 is safe in healthy adult participants. It will also learn about the PK and PD profiles of ART105. The main questions it aims to answer are:

Is ART105 safe and tolerable in adult participants? How does the ART105 influence the urine PC1 level of participants?

Participants will:

recieve single dose of ART105 and visit the clinic 3 months

Conditions

  • Healthy

Interventions

DRUG

ART105

injection

DRUG

Placebo

injection

Sponsors & Collaborators

  • Arnatar Therapeutics, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-03
Primary Completion
2027-02-25
Completion
2027-02-25

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07748026 on ClinicalTrials.gov